Repeat Course of Antenatal Corticosteroids After One Week
A single repeat course of antenatal corticosteroids can be administered one week (7 days) after the previous course if the patient remains at risk of preterm delivery before 34 0/7 weeks of gestation.
Clinical Decision Framework
For Gestations <34 0/7 Weeks
Yes, repeat dosing at 7 days is supported when:
- The patient received their initial course more than 7 days ago
- They remain at high risk of preterm delivery within the next 7 days
- Current gestational age is still less than 34 0/7 weeks
The ACOG guideline explicitly states that "a single repeat course of antenatal corticosteroids should be considered in women who are less than 34 0/7 weeks of gestation who are at risk of preterm delivery within 7 days, and whose prior course of antenatal corticosteroids was administered more than 14 days previously" 1. However, the same guideline clarifies that rescue course corticosteroids could be provided as early as 7 days from the prior dose, if indicated by the clinical scenario 1.
The Cochrane systematic review (2022) provides high-certainty evidence supporting this approach, demonstrating that repeat doses reduce respiratory distress syndrome (RR 0.82,95% CI 0.74-0.90; NNTB 16) and probably reduce composite serious infant outcomes (RR 0.88,95% CI 0.80-0.97; NNTB 39) 2. Importantly, moderate- to high-certainty evidence shows no significant harm in early or mid-childhood neurodevelopmental outcomes 2.
For Gestations 34 0/7 to 36 6/7 Weeks
No, repeat courses are not recommended in the late preterm period. The SMFM guidelines specifically recommend offering a single course of antenatal corticosteroids to patients between 34 0/7 and 36 6/7 weeks who are at high risk of preterm birth within the next 7 days 3. The evidence base (ALPS trial) excluded patients who had received previous courses of corticosteroids 3.
Dosing Regimen
When administering a repeat course:
- Betamethasone: 2 doses of 12 mg intramuscularly, 24 hours apart
- This is the same dosing as the initial course
Key Timing Considerations
The optimal benefit window is 1-7 days between steroid administration and delivery 4. This creates a clinical dilemma:
- Neonatal benefit is lost after 7 days from the initial course
- Over half of women who deliver before 34 weeks don't receive corticosteroids within the optimal timeframe 5
- This justifies repeat dosing when delivery hasn't occurred and risk persists
Important Caveats and Contraindications
Avoid multiple repeat courses: While a single repeat course is beneficial, weekly repeat courses are associated with reduced fetal growth and should be avoided 4. The evidence supports one repeat course only, not ongoing weekly administration.
Exercise caution in:
- Growth-restricted fetuses with absent or reversed end-diastolic umbilical artery flow (increased risk of acidosis and perinatal death) 4
- Patients with pregestational diabetes mellitus (increased risk of neonatal hypoglycemia) 3
Safety Profile
The moderate-certainty evidence from follow-up studies is reassuring:
- No significant increase in neurodevelopmental impairment at early childhood (RR 0.97,95% CI 0.85-1.10) 2
- No effect on survival without neurodevelopmental impairment (RR 1.01,95% CI 0.98-1.04) 2
- At mid-childhood, no effect on survival free of neurocognitive impairment (RR 1.01,95% CI 0.95-1.08) 2
The short-term neonatal benefits clearly outweigh the risks when appropriately indicated, particularly for reducing respiratory distress and serious health problems in the first weeks after birth 2.